Presentation is loading. Please wait.

Presentation is loading. Please wait.

Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970–1979 1974: FDA approves doxorubicin, a vital part of combination chemotherapy.

Similar presentations


Presentation on theme: "Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970–1979 1974: FDA approves doxorubicin, a vital part of combination chemotherapy."— Presentation transcript:

1 Progress Against Lymphoma

2 1970–1979

3 Progress Against Lymphoma 1970–1979 1974: FDA approves doxorubicin, a vital part of combination chemotherapy

4 Progress Against Lymphoma 1970–1979 1975: New chemotherapy regimen boosts Hodgkin lymphoma cure rates to 70 percent 1975: Era of bone marrow transplantation begins – extending lives of many patients with leukemia and lymphoma

5 Progress Against Lymphoma 1970–1979 1976: CHOP regimen boosts cure rates for non- Hodgkin lymphoma

6 Progress Against Lymphoma 1980–1989

7 Progress Against Lymphoma 1980–1989 1980: Imaging tests begin replacing surgery for Hodgkin lymphoma staging

8 Progress Against Lymphoma 1980–1989 Late 1980s: Benzene established to cause blood cancers

9 Progress Against Lymphoma 1990–1999

10 Progress Against Lymphoma 1990–1999 1993: Mantle cell lymphoma recognized as a subtype of non-Hodgkin lymphoma

11 Progress Against Lymphoma 1990–1999 1990s: Research suggests a therapeutic vaccine for follicular lymphoma could be possible 1995: Lymphocyte transfusions re-induce leukemia remissions 1995: Bone marrow transplantation improves survival for relapsed non-Hodgkin lymphoma

12 Progress Against Lymphoma 1990–1999 1997: FDA approves first-ever targeted cancer drug, rituximab 1997: Classification system established for non- Hodgkin lymphoma

13 Progress Against Lymphoma 1990–1999 1998: New technique enables older patients to undergo life-saving stem cell transplants

14 Progress Against Lymphoma 2000–Present

15 Progress Against Lymphoma 2000–Present 2001: Scientists discover that common type of lymphoma is two distinct diseases

16 Progress Against Lymphoma 2000–Present 2002: Adding rituximab to ''CHOP'' chemotherapy boosts survival 2002: Radioimmunotherapy introduced to treat lymphoma

17 Progress Against Lymphoma 2000–Present 2005: Bortezomib shrinks tumors in mantle cell lymphoma

18 Progress Against Lymphoma 2000–Present 2007: PET scanning helps guide lymphoma treatment

19 Progress Against Lymphoma 2000–Present 2008: First drug approved specifically for T-cell lymphoma treatment

20 Progress Against Lymphoma Five-Year Survival Source: National Cancer Institute

21 Progress Against Lymphoma Mortality Source: National Cancer Institute

22 Progress Against Lymphoma New Cases Source: National Cancer Institute

23 Visit CancerProgress.Net for an interactive timeline of progress against a range of common cancers CancerProgress.Net is a project of the American Society of Clinical Oncology, which represents nearly 30,000 physicians who treat people with cancer and research new cures


Download ppt "Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970–1979 1974: FDA approves doxorubicin, a vital part of combination chemotherapy."

Similar presentations


Ads by Google